The Establishment of a Registry and a Biorepository of Patients With Suspected Amniotic Fluid Embolism (AFE)

Description

To establish a clinical registry of suspected cases of AFE. The existing registry will be migrated to a new platform,

Conditions

Amniotic Fluid Embolism

Talk to us

Study Overview

On this page

Study Details

Study overview

To establish a clinical registry of suspected cases of AFE. The existing registry will be migrated to a new platform,

The Establishment of a Registry and a Biorepository of Patients With Suspected Amniotic Fluid Embolism (AFE)

The Establishment of a Registry and a Biorepository of Patients With Suspected Amniotic Fluid Embolism (AFE)

Condition
Amniotic Fluid Embolism
Intervention / Treatment

-

Contacts and Locations

Houston

The University of Texas Health Science Center at Houston, Houston, Texas, United States, 77030

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * The inability of an individual to provide a signed and dated informed consent form or those who do not wish to participate.

Ages Eligible for Study

to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

The University of Texas Health Science Center, Houston,

Irene Stafford, MD, PRINCIPAL_INVESTIGATOR, UT Health Science Center Health Science Center

Study Record Dates

2031-12-31